Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Oral Anti-Diabetic Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Oral Anti-Diabetic Drug market. Detailed analysis of key players, along with key growth strategies adopted by Oral Anti-Diabetic Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Abbott
Pfizer
AstraZeneca
Eli Lilly
Merck And Co
Takeda
Boehringer Ingelheim
Janssen Pharmaceuticals
Novartis
Biocon
Astellas
Sanofi
Bristol Myers Squibb
By Type:
Glimepiride
Gliclazide
Glyburide
Others
By End-User:
Hospital
Research Institual
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Oral Anti-Diabetic Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Glimepiride from 2016 to 2027
-
1.3.2 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Gliclazide from 2016 to 2027
-
1.3.3 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Glyburide from 2016 to 2027
-
1.3.4 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Research Institual from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Oral Anti-Diabetic Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Oral Anti-Diabetic Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Glimepiride
-
3.4.2 Market Size and Growth Rate of Gliclazide
-
3.4.3 Market Size and Growth Rate of Glyburide
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Oral Anti-Diabetic Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Oral Anti-Diabetic Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Oral Anti-Diabetic Drug in Hospital
-
4.4.2 Market Size and Growth Rate of Oral Anti-Diabetic Drug in Research Institual
5 Market Analysis by Regions
-
5.1 China Oral Anti-Diabetic Drug Production Analysis by Regions
-
5.2 China Oral Anti-Diabetic Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Oral Anti-Diabetic Drug Landscape Analysis
-
6.1 North China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
6.2 North China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
7 Central China Oral Anti-Diabetic Drug Landscape Analysis
-
7.1 Central China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
7.2 Central China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
8 South China Oral Anti-Diabetic Drug Landscape Analysis
-
8.1 South China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
8.2 South China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
9 East China Oral Anti-Diabetic Drug Landscape Analysis
-
9.1 East China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
9.2 East China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
10 Northeast China Oral Anti-Diabetic Drug Landscape Analysis
-
10.1 Northeast China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
10.2 Northeast China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
11 Southwest China Oral Anti-Diabetic Drug Landscape Analysis
-
11.1 Southwest China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
11.2 Southwest China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
12 Northwest China Oral Anti-Diabetic Drug Landscape Analysis
-
12.1 Northwest China Oral Anti-Diabetic Drug Landscape Analysis by Major Types
-
12.2 Northwest China Oral Anti-Diabetic Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Abbott
-
13.1.1 Abbott Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AstraZeneca
-
13.3.1 AstraZeneca Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly
-
13.4.1 Eli Lilly Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Merck And Co
-
13.5.1 Merck And Co Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Takeda
-
13.6.1 Takeda Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Boehringer Ingelheim
-
13.7.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Janssen Pharmaceuticals
-
13.8.1 Janssen Pharmaceuticals Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Novartis
-
13.9.1 Novartis Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Biocon
-
13.10.1 Biocon Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Astellas
-
13.11.1 Astellas Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Sanofi
-
13.12.1 Sanofi Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
-
13.13 Bristol Myers Squibb
-
13.13.1 Bristol Myers Squibb Company Profile and Recent Development
-
13.13.2 Market Performance
-
13.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Glimepiride from 2016 to 2027
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Gliclazide from 2016 to 2027
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Glyburide from 2016 to 2027
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Research Institual from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Oral Anti-Diabetic Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Oral Anti-Diabetic Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Oral Anti-Diabetic Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Oral Anti-Diabetic Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Glimepiride
-
Figure Market Size and Growth Rate of Gliclazide
-
Figure Market Size and Growth Rate of Glyburide
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Oral Anti-Diabetic Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Oral Anti-Diabetic Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Research Institual
-
Table China Oral Anti-Diabetic Drug Production by Regions
-
Table China Oral Anti-Diabetic Drug Production Share by Regions
-
Figure China Oral Anti-Diabetic Drug Production Share by Regions in 2016
-
Figure China Oral Anti-Diabetic Drug Production Share by Regions in 2021
-
Figure China Oral Anti-Diabetic Drug Production Share by Regions in 2027
-
Table China Oral Anti-Diabetic Drug Consumption by Regions
-
Table China Oral Anti-Diabetic Drug Consumption Share by Regions
-
Figure China Oral Anti-Diabetic Drug Consumption Share by Regions in 2016
-
Figure China Oral Anti-Diabetic Drug Consumption Share by Regions in 2021
-
Figure China Oral Anti-Diabetic Drug Consumption Share by Regions in 2027
-
Table North China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table North China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table North China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table North China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure North China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table Central China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table Central China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table Central China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure Central China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table South China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table South China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table South China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table South China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure South China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table East China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table East China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table East China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table East China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure East China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table Northeast China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table Northeast China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table Southwest China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table Southwest China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table Northwest China Oral Anti-Diabetic Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Oral Anti-Diabetic Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2016
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2021
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by Types in 2027
-
Table Northwest China Oral Anti-Diabetic Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Oral Anti-Diabetic Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Oral Anti-Diabetic Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Merck And Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck And Co
-
Figure Sales and Growth Rate Analysis of Merck And Co
-
Figure Revenue and Market Share Analysis of Merck And Co
-
Table Product and Service Introduction of Merck And Co
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Janssen Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals
-
Table Product and Service Introduction of Janssen Pharmaceuticals
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Astellas
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas
-
Figure Sales and Growth Rate Analysis of Astellas
-
Figure Revenue and Market Share Analysis of Astellas
-
Table Product and Service Introduction of Astellas
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Bristol Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol Myers Squibb
-
Table Product and Service Introduction of Bristol Myers Squibb
-
